Abstract
GM1-gangliosidosis is a genetic neurological disorder caused by mutations in the lysosomal acid beta-galactosidase gene. While its phenotypic expression is complex, it is usually classified as being of infantile, juvenile, or adult form, on the basis of age at onset, the rate of symptomatic progression, and severity of central nervous system involvement. We have analyzed the acid beta-galactosidase gene in 12 Japanese patients from nine families. The aim was to identify mutations in individual patients and then to examine possible correlation between the mutations and the clinical phenotypes. Northern blotting studies with a full-length human beta-galactosidase cDNA showed that the mRNA ranged from undetectable to substantially decreased in the infantile patients but was normal in quantity and size in all juvenile and adult patients. Four distinct missense mutations have been identified, each limited to the respective clinical forms within our small-size samples. In the infantile patient with decreased but detectable mRNA, a point mutation was found resulting in Arg49----Cys. In the infantile patient with nearly undetectable mRNA, mutation Arg457----Ter was identified. The mutation Arg201----Cys was found in all four of the juvenile patients, while all six adult patients were homozygous for the point mutation Ile51----Thr. The mutations found in the juvenile and adult patients alter restriction sites in the normal gene and thus are amendable to quick screening. The prediction that these mutations are responsible for the clinical disease was confirmed by no expression of the catalytic activity of the mutant proteins in the COS-I cell expression system.(ABSTRACT TRUNCATED AT 250 WORDS)
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arbisser A. I., Donnelly K. A., Scott C. I., Jr, DiFerrante N., Singh J., Stevenson R. E., Aylesworth A. S., Howell R. R. Morquio-like syndrome with beta galactosidase deficiency and normal hexosamine sulfatase activity: mucopolysacchariodosis IVB. Am J Med Genet. 1977;1(2):195–205. doi: 10.1002/ajmg.1320010205. [DOI] [PubMed] [Google Scholar]
- Morreau H., Galjart N. J., Gillemans N., Willemsen R., van der Horst G. T., d'Azzo A. Alternative splicing of beta-galactosidase mRNA generates the classic lysosomal enzyme and a beta-galactosidase-related protein. J Biol Chem. 1989 Dec 5;264(34):20655–20663. [PubMed] [Google Scholar]
- Nanba E., Suzuki K. Molecular cloning of mouse acid beta-galactosidase cDNA: sequence, expression of catalytic activity and comparison with the human enzyme. Biochem Biophys Res Commun. 1990 Nov 30;173(1):141–148. doi: 10.1016/s0006-291x(05)81033-2. [DOI] [PubMed] [Google Scholar]
- O'Brien J. S., Gugler E., Giedion A., Wiessmann U., Herschkowitz N., Meier C., Leroy J. Spondyloepiphyseal dysplasia, corneal clouding, normal intelligence and acid beta-galactosidase deficiency. Clin Genet. 1976 May;9(5):495–504. doi: 10.1111/j.1399-0004.1976.tb01603.x. [DOI] [PubMed] [Google Scholar]
- Okada S., O'Brien J. S. Generalized gangliosidosis: beta-galactosidase deficiency. Science. 1968 May 31;160(3831):1002–1004. doi: 10.1126/science.160.3831.1002. [DOI] [PubMed] [Google Scholar]
- Oshima A., Tsuji A., Nagao Y., Sakuraba H., Suzuki Y. Cloning, sequencing, and expression of cDNA for human beta-galactosidase. Biochem Biophys Res Commun. 1988 Nov 30;157(1):238–244. doi: 10.1016/s0006-291x(88)80038-x. [DOI] [PubMed] [Google Scholar]
- Sacrez R., Juif J. G., Gigonnet J. M., Gruner J. E. La maladie de Landing ou idiotie amaurotique infantile précoce avec gangliosidose généralisée de type GM 1. Pediatrie. 1967 Mar;22(2):143–162. [PubMed] [Google Scholar]
- Seringe P., Plainfosse B., Lautmann F., Lorilloux J., Calamy G., Berry J. P., Watchi J. M. Gangliosidose généralisée, du type Norman-Landing, à GM1: étude à propos d'un cas diagnostiqué du vivant du malade. Ann Pediatr (Paris) 1968 Mar 2;15(3):165–184. [PubMed] [Google Scholar]
- Suzuki K. Enzymatic diagnosis of sphingolipidoses. Methods Enzymol. 1987;138:727–762. doi: 10.1016/0076-6879(87)38063-2. [DOI] [PubMed] [Google Scholar]
- Tanaka A., Ohno K., Sandhoff K., Maire I., Kolodny E. H., Brown A., Suzuki K. GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients. Am J Hum Genet. 1990 Feb;46(2):329–339. [PMC free article] [PubMed] [Google Scholar]
- Yoshida K., Oshima A., Shimmoto M., Fukuhara Y., Sakuraba H., Yanagisawa N., Suzuki Y. Human beta-galactosidase gene mutations in GM1-gangliosidosis: a common mutation among Japanese adult/chronic cases. Am J Hum Genet. 1991 Aug;49(2):435–442. [PMC free article] [PubMed] [Google Scholar]